Sou Hu Cai Jing·2025-12-16 00:17Core Viewpoint - Liaoning Chengda is focusing on clearing development obstacles to unleash its innovative potential, as stated by Chairman Xu Biao in a recent interview [3][4]. Financial Performance - In the first three quarters of this year, the net profit attributable to shareholders after deducting non-recurring gains and losses increased by 92.20% year-on-year, total assets grew by 2.79% compared to the beginning of the year, and the debt-to-asset ratio decreased by 1.98 percentage points [3]. - As of the end of September, the proportion of long-term loans in total liabilities increased to 14.91%, up by 7.87 percentage points from the beginning of the year, while the proportion of short-term loans decreased to 32.32%, down by 5.19 percentage points [4]. Governance and Shareholder Support - The board restructuring at the beginning of the year was not merely a change in controlling shareholders but a consensus among various shareholders, with Guangdong Min Investment holding approximately 16% of the shares [4]. - The new board and management team include professionals with risk control and investment banking backgrounds, providing solid support for the company's sustainable development [4]. Strategic Focus and Business Optimization - The company has decided to long-term suspend operations at its subsidiary Baoming Mining and will not make significant cash investments in it, focusing instead on attracting strategic investors [6]. - The company aims to improve profitability by reducing weaker business segments while continuing to invest in core industries, particularly in biopharmaceuticals [7]. Investment in Core Industries - Chengda Biopharmaceutical, a core subsidiary, is a focus area for resource integration to enhance research and market positioning [7]. - The company plans to leverage its financial strength to cultivate a second growth curve in innovative vaccines and therapeutic drugs [7][8]. Future Development Plans - Liaoning Chengda has defined its positioning as a "technology industry group based on stable financial investments," while also planning to develop new-generation information technology [9]. - A strategic investment team has been established to explore high-value technology sectors, with plans for mergers and acquisitions to strengthen industry foundations when market conditions are favorable [9].